Lymph Node Pathologic Grading Strategy
NCT06745830 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2998
Last updated 2024-12-20
Summary
The percentage of high-grade patterns in metastatic LNs (mLNs) that can predict poor outcomes has yet to be determined. Additionally, the potential implications of other histologic patterns in metastatic lymph nodes on patient outcomes warrant further investigation.
We conducted a retrospective cohort study to investigate the prognostic value of pathologic pattern in metastatic lymph nodes.
Conditions
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Fudan University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-10
- Primary Completion
- 2024-12-30
- Completion
- 2025-04-20
Countries
- China
Study Locations
More Related Trials
-
Mapping of Lymph Node Metastasis and Survival For pN+ Superficial Esophageal Squamous Cell Carcinoma
NCT05526456 ·Status: COMPLETED
-
Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC)
NCT05706883 ·Status: COMPLETED
-
Molecular Signature From Tumor to Lymph Nodes
NCT04677205 ·Status: RECRUITING
-
Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer
NCT06496360 ·Status: RECRUITING
-
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT00732563 ·Status: COMPLETED ·Phase: NA
-
Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study
NCT06484127 ·Status: COMPLETED
-
Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer
NCT00213733 ·Status: COMPLETED
-
Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness
NCT06292052 ·Status: COMPLETED
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN
-
A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)
NCT06829147 ·Status: RECRUITING
-
Systematic Sampling of Lymph Nodes vs. Lymphadenectomy According to Intraoperative Frozen Pathology for Pulmonary Invasive Adenocarcinoma With Ground-glass Opacity
NCT03322826 ·Status: UNKNOWN ·Phase: NA
-
Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm
NCT06634979 ·Status: RECRUITING ·Phase: NA
-
Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy
NCT03845764 ·Status: COMPLETED
-
Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC
NCT07003490 ·Status: RECRUITING ·Phase: NA
-
WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma
NCT05925764 ·Status: RECRUITING
-
Prognostic Significance of the Uncertain Resection in NSCLC
NCT06511661 ·Status: ACTIVE_NOT_RECRUITING
-
Feasibility of Radioisotope-guided Excision of Mediastinal Lymph Nodes in Patients With Non-small Cells Lung Carcinoma
NCT05072561 ·Status: UNKNOWN ·Phase: NA
-
Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection
NCT01376856 ·Status: TERMINATED
-
Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
NCT07050576 ·Status: RECRUITING
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
NCT04419935 ·Status: UNKNOWN
-
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
NCT03413956 ·Status: COMPLETED
-
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
NCT05834413 ·Status: RECRUITING ·Phase: NA
-
Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer
NCT02991924 ·Status: ACTIVE_NOT_RECRUITING
-
Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules
NCT04554875 ·Status: UNKNOWN